These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8386959)

  • 1. Spontaneous hepatic rupture in postmenopausal women receiving oral estrogen replacement.
    Lundell CJ
    J Vasc Interv Radiol; 1993; 4(2):245-9. PubMed ID: 8386959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone replacement therapy in menopause].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmenopausal endometrioma and hormonal replacement therapy.
    Goh JT; Hall BA
    Aust N Z J Obstet Gynaecol; 1992 Nov; 32(4):384-5. PubMed ID: 1337826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials.
    Rossouw JE; Harlan WR
    Ann Epidemiol; 1994 May; 4(3):255-6. PubMed ID: 8055127
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 9. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormones: where do we go from here?
    Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
    [No Abstract]   [Full Text] [Related]  

  • 12. Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women.
    Boschetti C; Cortellaro M; Nencioni T; Bertolli V; Della Volpe A; Zanussi C
    Thromb Res; 1991 Apr; 62(1-2):1-8. PubMed ID: 1649497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of a middle ground: hormone therapy and its role in modern menopause management.
    Shulman LP
    Menopause; 2010; 17(5):898-9. PubMed ID: 20717059
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of menopause-related symptoms.
    Danby FW
    Ann Intern Med; 2005 Dec; 143(11):845-6; author reply 846. PubMed ID: 16330803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
    [No Abstract]   [Full Text] [Related]  

  • 19. Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
    Pinkerton JV; Bushmakin AG; Bobula J; Lavenberg J; Komm BS; Abraham L
    Menopause; 2017 Dec; 24(12):1372-1377. PubMed ID: 28609389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual cause of recurrent chorea.
    Caviness JN; Muenter MD
    Mov Disord; 1991; 6(4):355-7. PubMed ID: 1661846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.